Adicet Bio, Inc Alternatives & Competitors
12 companies similar to Adicet Bio, Inc — A biotechnology company discovering and developing first-in-class allogeneic gam...
Companies similar to Adicet Bio, Inc
Gracell Biotechnologies
A Member of the AstraZeneca Group
Shanghai, China
Nkarta, Inc.
A New Way Forward for Autoimmune Disease
South San Francisco, Unit...
Angeles Therapeutics, Inc.
A next generation CAR-T and CAR-NK cell therapy company
Los Angeles, United State...
Fate Therapeutics Inc.
Transforming the lives of patients with autoimmune diseases and cancer.
San Diego, United States
Track all Adicet Bio, Inc competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Umoja Biopharma
Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer b...
Tessa Therapeutics Ltd
A clinical-stage biotech company developing autologous and allogeneic cell therapies for t...
Singapore, Singapore
Neogene Therapeutics
Pushing the frontier by pioneering next-generation engineered T cell receptor therapies fo...
Amsterdam, The Netherland...
TScan Therapeutics
Unleash Immunity
Waltham, United States
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
Kite Pharma
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
Santa Monica, United Stat...
Legend Biotech
Multinational biopharmaceutical company focused on discovering and developing cutting-edge...
Somerset, United States
ONK Therapeutics
Pioneering optimally engineered NK cell therapies to cure patients with cancer.
Galway, Ireland
About Adicet Bio, Inc
Adicet Bio, Inc, a leading innovator in the biopharma and biotechnology sectors, focuses on discovering and developing first-in-class allogeneic gamma delta CAR T cell therapies to combat cancer and autoimmune diseases. Founded in 2014 and headquartered in the United States, Adicet prides itself on its pioneering role...
Gamma Delta T Cell Therapies, Allogeneic Gamma Delta CAR T Cell Therapy, Cancer and Autoimmune Disease Research
Patients with Autoimmune Diseases, Cancer Patients, Healthcare Providers, Biotech Investors
Cell Therapy, Gamma-delta T Cells, Allogeneic Therapies, CAR T Cell Therapies, Cancer Treatment, Autoimmune Diseases, Immune Reset, Solid Tumors, Tumor Targeting, Innate Immune Response, Adaptive Immune Response, Off-the-shelf Therapies, Biopharma Innovation, Chimeric Antigen Receptors
B2B, B2C, B2D
Licensing, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Adicet Bio, Inc and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Adicet Bio, Inc on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 29 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
